Oncology diagnostics are in a renaissance of new development driven by the rise of liquid biopsy technologies that enable early, non-invasive cancer detection through blood, saliva, or urine samples. Bringing these innovative assays to market requires tailored clinical trials that validate performance against current standard-of-care methods. Unlike traditional drug trials, liquid biopsy studies face unique challenges in design, execution, and regulatory approval.

This webinar focuses on critical considerations for planning and executing clinical trials for liquid biopsy diagnostics, examining how the path to market is uniquely shaped by key decisions made during early study design and operational planning, including how to determine sample size and target populations, strategies for efficiently recruiting study cohorts, factors for choosing comparators and setting benchmarks to meet regulatory and payor requirements, and much more.

Whether you’re a diagnostics sponsor, clinical operations professional, or regulatory expert, this webinar will provide practical methods to design and execute high-quality research while prioritizing participant experience.